The global pain management devices market size was valued at $4,017 million in 2018, and is projected to reach $6,777 million by 2026, registering a CAGR of 6.7% from 2019 to 2026. 

Pain management is a branch of medical science, which eases the suffering of the patients who have chronic pain. Acute pain has sudden onset of action, whereas chronic pain persist for a longer duration, which leads to need for its management. Pain management devices are medical device that are used in management of different types of pain such as neuropathic pain, cancer pain, nociceptive pain, musculoskeletal pain, and others. Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are various types of pain management devices available in the market. 

Get more information on this report : Request Sample Pages

The growth of the global pain management devices market is driven by increase in geriatric population, rise in prevalence of chronic pain, surge in geriatric population, surge in awareness among people towards pain management devices, improved R&D investment to develop innovative products, and launch of innovative products. 

In addition, increase in demand for pain management devices among the developing countries and rise in adoption of pain management devices for management of chronic pain are other factors that contribute toward the growth of the market. Furthermore, untapped potential offered by developing economies present lucrative opportunities for market expansion during the forecast period. However, hypersensitivity reactions and post-operative infections caused due the use of these devices limit their adoption, which hampers the growth of the market. Moreover, these devices are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy, which limits the growth of the global pain management devices market. 

Pain Management Devices Market Segmentation  

The pain management devices market is segmented into product, application, and region. Depending on product, the market is categorized into neuromodulation & neurostimulation devices, analgesic infusion pumps, and ablation devices. The applications covered in the study include cancer pain, neuropathic pain, cancer pain, facial & migraine pain, musculoskeletal pain, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Segment Review 

On the basis of product, the pain management devices market is categorized into neuromodulation & neurostimulation devices, analgesic infusion pumps, and ablation devices. Presently, the neuromodulation & neurostimulation devices dominates the global market, and is anticipated to continue this trend over the forecast period, due surge in demand for neuromodulation & neurostimulation devices, cost efficiency offered by these devices, increase in target population. 

[PRODUCTTYPEGRAPH]

Get more information on this report : Request Sample Pages

By application, the market is classified into neuropathic pain, cancer pain, facial & migraine pain, musculoskeletal pain, and others. At present, the neuropathic pain accounts for the majority of market share, owing to surge in number of target population, technological advancements in pain management devices, surge in demand of pain management devices for management of neuropathic pain. 

[APPLICATIONGRAPH]

Get more information on this report : Request Sample Pages

Snapshot Of Asia-Pacific Pain Management Devices Market  

Asia-Pacific presents lucrative opportunities for the key players operating in the pain management devices market, owing to surge in awareness about implantable pain management devices and rise in adoption of pain management devices products. Improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced medical facilities, development of the R&D sector, increase in number of target population, rise in healthcare reforms, and technological advancements in the field of healthcare further contribute toward the market growth. Some other factors such as surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high growth potential, presence of large patient base, and high disposable income are expected to drive the growth of pain management devices market in Asia-Pacific.

[GEOGRAPHYGRAPH]

Get more information on this report : Request Sample Pages

The key players profiled in this report include Abbott Laboratories, B Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp., DJO Global LLC., Johnson & Johnson (Codman And Shurtleff, Inc.,), Kimberly Clark Corporation, Medtronic Plc., Pfizer, Inc., and Stryker Corp.  

Key Benefits for Stakeholders:

• The study provides an in-depth analysis of the pain management devices market size along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers pain management devices market analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
• A comprehensive analysis of all the geographical regions is provided to determine the prevailing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global pain management devices market growth.

Key Market Segments:

By Product Type 

• Neuromodulation & Neurostimulation Devices
• Analgesic Infusion Pumps
• Ablation Devices 

By Application 

• Neuropathic Pain
• Cancer Pain
• Facial & Migraine Pain
• Musculoskeletal Pain
• Others 

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Market player positioning, 2018

3.3. Porter’s five force analysis
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in prevalence of chronic disease
3.4.1.2. Rise in in geriatric population
3.4.1.3. Increase in adoption of pain management devices

3.4.2. Restraint

3.4.2.1. Preferable use of medications for pain management

3.4.3. Opportunities

3.4.3.1. Growth opportunities in emerging markets

3.4.4. Impact analysis

CHAPTER 4: PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Neuromodulation & Neurostimulation devices

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type

4.2.2.1. Spinal cord stimulators

4.2.2.1.1. Market size and forecast

4.2.2.2. Transcutaneous Electrical Nerve Stimulation (TENS) Devices

4.2.2.2.1. Market size and forecast

4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country

4.3. Analgesic Infusion Pumps

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by type

4.3.2.1. External infusion pumps

4.3.2.1.1. Market size and forecast

4.3.2.2. Intrathecal Infusion Pumps

4.3.2.2.1. Market size and forecast

4.3.3. Market size and forecast
4.3.4. Market analysis, by country

4.4. Ablation Devices

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

CHAPTER 5: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Neuropathic pain

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Cancer pain

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Facial & migraine pain

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

5.5. Musculoskeletal pain

5.5.1. Market size and forecast
5.5.2. Market analysis, by country

5.6. Others

5.6.1. Market size and forecast
5.6.2. Market analysis, by country

CHAPTER 6: PAIN MANAGEMENT DEVICES MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country

6.2.2.1. U.S.

6.2.2.1.1. U.S. pain management devices market, by product type
6.2.2.1.2. U.S. pain management devices market, by application

6.2.2.2. Canada

6.2.2.2.1. Canada pain management devices market, by product type
6.2.2.2.2. Canada pain management devices market, by application

6.2.2.3. Mexico

6.2.2.3.1. Mexico pain management devices market, by product type
6.2.2.3.2. Mexico pain management devices market, by application

6.2.3. North America market size and forecast, by product type
6.2.4. North America pain management devices market, by application

6.3. Europe

6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country

6.3.2.1. Germany

6.3.2.1.1. Germany pain management devices market, by product type
6.3.2.1.2. Germany pain management devices market, by application

6.3.2.2. France

6.3.2.2.1. France pain management devices market, by product type
6.3.2.2.2. France pain management devices market, by application

6.3.2.3. UK

6.3.2.3.1. UK pain management devices market, by product type
6.3.2.3.2. UK pain management devices market, by application

6.3.2.4. Italy

6.3.2.4.1. Italy pain management devices market, by product type
6.3.2.4.2. Italy pain management devices market, by application

6.3.2.5. Spain

6.3.2.5.1. Spain pain management devices market, by product type
6.3.2.5.2. Spain pain management devices market, by application

6.3.2.6. Rest of Europe

6.3.2.6.1. Rest of Europe pain management devices market, by product type
6.3.2.6.2. Rest of Europe pain management devices market, by application

6.3.3. Europe market size and forecast, by product type
6.3.4. Europe pain management devices market, by application

6.4. Asia-Pacific

6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country

6.4.2.1. Japan

6.4.2.1.1. Japan pain management devices market, by product type
6.4.2.1.2. Japan pain management devices market, by application

6.4.2.2. China

6.4.2.2.1. China pain management devices market, by product type
6.4.2.2.2. China pain management devices market, by application

6.4.2.3. Australia

6.4.2.3.1. Australia pain management devices market, by product type
6.4.2.3.2. Australia pain management devices market, by application

6.4.2.4. India

6.4.2.4.1. India pain management devices market, by product type
6.4.2.4.2. India pain management devices market, by application

6.4.2.5. South Korea

6.4.2.5.1. South Korea pain management devices market, by product type
6.4.2.5.2. South Korea pain management devices market, by application

6.4.2.6. Rest of Asia-Pacific

6.4.2.6.1. Rest of Asia-Pacific pain management devices market, by product type
6.4.2.6.2. Rest of Asia-Pacific pain management devices market, by application

6.4.3. Asia-Pacific market size and forecast, by product type
6.4.4. Asia-Pacific pain management devices market, by application

6.5. LAMEA

6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country

6.5.2.1. Brazil

6.5.2.1.1. Brazil pain management devices market, by product type
6.5.2.1.2. Brazil pain management devices market, by application

6.5.2.2. Saudi Arabia

6.5.2.2.1. Saudi Arabia pain management devices market, by product type
6.5.2.2.2. Saudi Arabia pain management devices market, by application

6.5.2.3. South Africa

6.5.2.3.1. South Africa pain management devices market, by product type
6.5.2.3.2. South Africa pain management devices market, by application

6.5.2.4. Rest of LAMEA

6.5.2.4.1. Rest of LAMEA pain management devices market, by product type
6.5.2.4.2. Rest of LAMEA pain management devices market, by application

6.5.3. LAMEA market size and forecast, by product type
6.5.4. LAMEA pain management devices market, by application

CHAPTER 7: COMPANY PROFILES

7.1. Abbott Laboratories

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments

7.2. B Braun Melsungen Ag

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance

7.3. BAXTER INTERNATIONAL INC.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance

7.4. Boston Scientific Corporation

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments

7.5. DJO Global LLC

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance

7.6. Johnson & Johnson (Codman and Shurtleff, Inc.,)

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance

7.7. Kimberly-Clark Corporation (Baylis Medical)

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance

7.8. Medtronic Plc

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments

7.9. Pfizer Inc. (Hospira Inc.)

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance

7.10. Stryker Corporation

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance

LIST OF TABLES

TABLE 01. GLOBAL PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 02. NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 03. NEUROMODULATION & NEUROSTIMULATION DEVICES PAIN MANAGEMENT DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04. ANALGESIC INFUSION PUMPS MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 05. ANALGESIC INFUSION PUMPS PAIN MANAGEMENT DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 06. ABLATION DEVICES PAIN MANAGEMENT DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 07. GLOBAL PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 08. PAIN MANAGEMENT DEVICES MARKET FOR NEUROPATHIC PAIN, BY REGION, 2018–2026 ($MILLION)
TABLE 09. PAIN MANAGEMENT DEVICES MARKET FOR CANCER PAIN, BY REGION, 2018–2026 ($MILLION)
TABLE 10. PAIN MANAGEMENT DEVICES MARKET FOR FACIAL & MIGRAINE PAIN, BY REGION, 2018–2026 ($MILLION)
TABLE 11. PAIN MANAGEMENT DEVICES MARKET FOR MUSCULOSKELETAL PAIN, BY REGION, 2018–2026 ($MILLION)
TABLE 12. PAIN MANAGEMENT DEVICES MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 13. PAIN MANAGEMENT DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 14. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 15. U.S. PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 16. U.S. PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 17. CANADA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 18. CANADA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 19. MEXICO PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 20. MEXICO PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 21. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 22. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 23. EUROPE PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 24. GERMANY PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 25. GERMANY PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 26. FRANCE PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 27. FRANCE PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 28. UK PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 29. UK PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 30. ITALY PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 31. ITALY PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 32. SPAIN PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 33. SPAIN PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 34. REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 35. REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 36. EUROPE PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 37. EUROPE PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 38. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 39. JAPAN PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 40. JAPAN PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 41. CHINA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 42. CHINA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 43. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 44. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 45. INDIA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 46. INDIA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 47. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 48. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 49. REST OF ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 50. REST OF ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 51. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 52. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 53. LAMEA PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 54. BRAZIL PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 55. BRAZIL PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 56. SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 57. SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 58. SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 59. SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 60. REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 61. REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 62. LAMEA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 63. LAMEA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 64. ABBOTT: COMPANY SNAPSHOT
TABLE 65. ABBOTT: OPERATING SEGMENTS
TABLE 66. ABBOTT: PRODUCT PORTFOLIO
TABLE 67. B BRAUN: COMPANY SNAPSHOT
TABLE 68. B BRAUN: OPERATING SEGMENTS
TABLE 69. B BRAUN: PRODUCT PORTFOLIO
TABLE 70. BAXTER: COMPANY SNAPSHOT
TABLE 71. BAXTER: OPERATING SEGMENTS
TABLE 72. BAXTER: PRODUCT PORTFOLIO
TABLE 73. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 74. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 75. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 76. DJO: COMPANY SNAPSHOT
TABLE 77. DJO: OPERATING SEGMENTS
TABLE 78. DJO: PRODUCT PORTFOLIO
TABLE 79. J&J: COMPANY SNAPSHOT
TABLE 80. J&J: OPERATING SEGMENTS
TABLE 81. J&J: PRODUCT PORTFOLIO
TABLE 82. KIMBERLY-CLARK: COMPANY SNAPSHOT
TABLE 83. KIMBERLY-CLARK: OPERATING SEGMENTS
TABLE 84. KIMBERLY-CLARK: PRODUCT PORTFOLIO
TABLE 85. MEDTRONIC: COMPANY SNAPSHOT
TABLE 86. MEDTRONIC: OPERATING SEGMENTS
TABLE 87. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 88. PFIZER INC.: COMPANY SNAPSHOT
TABLE 89. PFIZER INC.: OPERATING SEGMENTS
TABLE 90. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 91. STRYKER: COMPANY SNAPSHOT
TABLE 92. STRYKER: OPERATING SEGMENTS
TABLE 93. STRYKER: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. GLOBAL PAIN MANAGEMENT DEVICES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. MARKET PLAYER POSITIONING, 2018
FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
FIGURE 06. MODERATE THREAT OF SUBSTITUTES
FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
FIGURE 08. HIGH INTENSITY OF RIVALRY
FIGURE 09. IMPACT ANALYSIS
FIGURE 10. SPINAL CORD STIMULATORS MARKET, 2018–2026, ($MILLION)
FIGURE 11. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) DEVICESS MARKET, 2018–2026, ($MILLION)
FIGURE 12. COMPARATIVE ANALYSIS OF NEUROMODULATION & NEUROSTIMULATION DEVICES PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 13. EXTERNAL INFUSION PUMPS MARKET, 2018–2026, ($MILLION)
FIGURE 14. INTRATHECAL INFUSION PUMPS MARKET, 2018–2026, ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF ANALGESIC INFUSION PUMPS PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF ABLATION DEVICES PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 17. COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR CANCER PAIN, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR FACIAL & MIGRAINE PAIN, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR MUSCULOSKELETAL PAIN, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 22. ABBOTT: NET SALES, 2016–2018 ($MILLION)
FIGURE 23. ABBOTT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 24. ABBOTT: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 25. B BRAUN: NET SALES, 2016–2018 ($MILLION)
FIGURE 26. B BRAUN: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27. B BRAUN: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 28. BAXTER: NET SALES, 2016–2018 ($MILLION)
FIGURE 29. BAXTER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 30. BAXTER: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 31. BOSTON SCIENTIFIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 32. BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 33. BOSTON SCIENTIFIC: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 34. DJO: NET SALES, 2016–2018 ($MILLION)
FIGURE 35. DJO: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 36. DJO: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 37. J&J: NET SALES, 2016–2018 ($MILLION)
FIGURE 38. J&J: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 39. J&J: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 40. KIMBERLY-CLARK: NET SALES, 2016–2018 ($MILLION)
FIGURE 41. KIMBERLY-CLARK: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 42. KIMBERLY-CLARK: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 43. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 44. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 45. MEDTRONIC: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 46. PFIZER INC.: NET SALES, 2016–2018 ($MILLION)
FIGURE 47. PFIZER INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48. PFIZER INC.: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 49. STRYKER: NET SALES, 2016–2018 ($MILLION)
FIGURE 50. STRYKER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 51. STRYKER: REVENUE SHARE BY REGION, 2018 (%)